SMAD4 and esophageal cancer: In esophageal cancer, the loss of SMAD4 correlates with the invasion depth and the pathologic stage (59) as well as with regional metastases and with decreased survival (30).In animal models for HNSCC, SMAD4 haploid insufficiency promoted tumor development (57).